ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Dr. Lal PathLabs will hold a board meeting on November 04, 2026, to consider and approve standalone and consolidated financial results for the quarter ending September 30, 2026.
Dr. Lal PathLabs' Board will meet on July 24, 2026. The meeting agenda includes approving quarterly results and considering an interim dividend.
Dr. Lal PathLabs scheduled a Board meeting on 24‑Jul‑2026 to approve its unaudited QJune‑30‑2026 results. Trading window will be closed from 1 to 26 July 2026.